|
|
You are encouraged to report negative side effects of prescription drugs to:
Phone: 0800-215-988
Mail: medicalscience@onenessbio.com.tw
Package Insert Download
|
Novel Mechanism Promotes Healing by Regulating M1/M2 Macrophages
and Rebalancing the Wound Microenvironment
Inhibit pro-inflammatory M1 φ and stimulate adipose precursor cells to secrete GCSF and CXCL3 to increase repairing M2a/M2c φ
Reference: Restoring Pro-healing/remodeling-associated M2a/c Macrophages using ON101 Accelerates Diabetic Wound Healing, JID Innovations (2022);2:100138, doi: https://doi.org/10.1016/j.xjidi.2022.100138.
| Superior Efficacy to Current Standard Care |
|
Incidence of Complete Healing - Full Analysis Set
FESPIXON® group achieved significant efficacy vs standard care (AQUACEL® Hydrofiber®) group (p=0.0001)
|
|
|
The Cumulative Rate of Complete Healing
The healing trend of FESPIXON® remained steady and robust at each observation time point.
|
|
|
Incidence of Complete Healing - Full Analysis Set
FESPIXON® group achieved significant efficacy vs standard care (AQUACEL® Hydrofbier®) group (p=0.0001)
|
|
|
The Cumulative Rate of Complete Healing
The healing trend of FESPIXON® remained steady and robust at each observation time point.
|
|
Reference: Effect of a Novel Macrophage-Regulating Drug on Wound Healing in Patients With Diabetic Foot Ulcers, JAMA Netw Open. 2021;4(9):e2122607, doi:10.1001/jamanetworkopen.2021.22607.
